Kenneth C. Frazier has a noteworthy stake in Merck & Co., showcasing his belief in the company's future. At last report, his personal holdings were valued around $81 million. This is significant for a CEO, as it aligns his interests...

Kenneth C. Frazier has a noteworthy stake in Merck & Co., showcasing his belief in the company's future. At last report, his personal holdings were valued around $81 million. This is significant for a CEO, as it aligns his interests closely with shareholders. Over the years, Frazier's wealth from Merck stock has seen notable fluctuations, especially given the company's strong performance in drug development and sales. For example, in years of strong company performance, his stock options and vested shares contributed substantially to his earnings. His holdings have been a key part of his overall compensation and wealth, highlighting his belief in Merck's ability to innovate and grow.